... of these initial trials indicate that the ZES is safe and reduces the rates of clinical and angiographic restenosis inpatientswith symptomatic coronaryarterydisease (CAD; 4) Also the safety ... Rosa, CA) for treating single de novo lesions inpatientswith symptomatic coronaryarterydisease has been examined inthe first four trials of the ongoing ENDEAVOR clinical trials program The ... Abbreviations ACC: American College of Cardiology; AHA: American Heart Association; CABG: coronaryartery binding graft; CK: creatine kinase; MACE: major adverse cardiac events; MI: myocardial infarction;...
... disease, including those of the gastrointestinal tract; (4) any change in pharmacological treatmentfor cardiovascular disease within one month of the start of the study; and (5) the administration ... 19:1099-104 Jax TW, Peters AJ, Khattab AA, Heintzen MP, Schoebel FC: Percutaneous coronary revascularization inpatientswith formerly “refractory angina pectoris in end-stage coronaryartery disease" -not ... significantly inthe values for their demographic and clinical data (Table 1), the only exception being frequent longacting nitrate use before the start of the study inpatients taking the placebo...
... Atorva = atorvastatin; Prava = Pravastatin; Simva = simvastatin the EURopean trial On Reduction of cardiac events with Perindopril in stable coronaryArterydisease (EUROPA)[34] and the Simvastatin/Enalapril ... prevention inpatientswithcoronary disease, they can be easily modified and appliedin other communities and for other target conditions Background and rationale Coronaryarterydisease (CAD) leads ... lowering in 4444 patientswithcoronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 1994, 344:1383-1389 The Long-Term Intervention with Pravastatin in Ischaemic Disease...
... disease, including those of the gastrointestinal tract; (4) any change in pharmacological treatmentfor cardiovascular disease within one month of the start of the study; and (5) the administration ... 19:1099-104 Jax TW, Peters AJ, Khattab AA, Heintzen MP, Schoebel FC: Percutaneous coronary revascularization inpatientswith formerly “refractory angina pectoris in end-stage coronaryartery disease" -not ... significantly inthe values for their demographic and clinical data (Table 1), the only exception being frequent longacting nitrate use before the start of the study inpatients taking the placebo...
... was involved in professional contacts so far Knowing each other was defined inthe questionnaire as ‘knowing the face, having talked to each with other, or having heard of.’ Having professional ... store and manage data files and UCINET for descriptions and statistical analysis Finally, we performed an explorative factor analysis (principal component analysis with orthogonal rotation) on the ... study, was responsible for data analysis, and wrote the paper ME was responsible for data collection and JK performed data analysis All authors critical feedback and approved the final manuscript...
... coronary events (75 angina, 25 MI and sudden cardiac deaths; had both angina and MI) inthe BP dataset, while the TC dataset contained 86 coronary events (71 angina, 20 MI and sudden cardiac deaths; ... rather than two Univariate comparisons For each of the TC and BP models, univariate comparisons of demographic, disease and treatment related variables and traditional cardiac risk factors in ... take a variable course inpatientswith SLE and that almost half of the total variance over time in both TC and BP is seen within rather than between patients [5] These findings suggest that the...
... was associated with poor overall clinical outcomes compared with outcomes associated with SES treatment Also, inthe multivariate analysis, after adjusting for clinical variables, we found that ... Association; CABG: coronaryartery binding graft; CK: creatine kinase; MACE: major adverse cardiac events; MI: myocardial infarction; PES: paclitaxel-eluting stent; RESEARCH: Rapamycin-Eluting ... implantation forthe percutaneous treatment of left main coronaryartery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH...
... physically measured or derived from architectural drawings A patient table captures vital information about the patient, namely, personal data such as name, age, sex, contact information, and most ... uses a dynamically changing graph Recall that there is a navigational choice at each node Whenever the user reaches a new node, the routing algorithm references the context table inthe database ... environment, accounting for physical abilities of the patient, environmental barriers and dynamic building changes The routing algorithm and database could be integrated into wearable and mobile platforms...
... design of the study and assisted inthe drafting of the manuscript CM participated inthe design of the study, performed the statistical analysis and assisted inthe drafting of the manuscript Acknowledgements ... both Cantonese and Mandarin-speaking Chinese would be able to read the Chinese version of the HADS In Europe, the HADS has been applied extensively inthe studies of patientswith CHD as an index ... publications reporting the HADS sub-scale means fora broad range of clinical groups Adopting a tridimensional scoring approach would essentially remove this valuable reference data for comparative...
... This was done by computing the mean value fora SF-36 domain, imputing that value for missing items in that domain, rounding imputed values to the nearest integer, and then recalculating the SF-6D ... at baseline (%)# p-value for change in PTCA* p-value for change in offpump CABG*¶ SF-6D ceiling effect at baseline (%)# p-value for change in PTCA* p-value for change in offpump CABG*¶ pain anxiety/ ... (0.12)¶ data are expressed as median (interquartile range) PTCA = percutaneous transluminal coronary angioplasty; CABG = coronaryartery bypass surgery *Kruskal-Wallis anova: p = 0.016 PTCA group...
... paper [14] The dataset was then divided in two by taking a random sample of 60% of the data and separating that data from the remaining 40% to provide an estimation dataset and a validation dataset, ... index as the dependent variable and age, sex and a proxy fordisease stage as explanatory variables inthe model using the estimation dataset The proxy 'disease stage' variable was created by taking ... estimation data with non-missing covariates inthe final model The variables inthe base model - age, sex and disease stage proxy - only explained 4% of the variation inthe EQ-5D index and gave an RMSE...
... of RA would have been recorded inthepatients' charts The diagnosis for RA was based on a rheumatologist's evaluation Coronary angiogram data Angiographic data was retrieved from the Mayo Clinic ... hyperlipidemia inthe model as covariates CABG, coronaryartery bypass surgery; CAD, coronaryartery disease; CI, confidence interval; CV, cardiovascular; HR, hazard ratio; MI, myocardial infarction; ... donors with stable angina and are significantly expanded inpatientswith unstable angina (P = 0.009) Patientswith RA and CAD resemble patientswith plaque instability and differ from those with...
... adalimumab, along with an evaluation of the two-year maintenance of fistula closure during treatmentwith adalimumab (ADHERE trial) [7] This analysis has shown that adalimumab therapy was associated ... monotherapy treatmentforthe long-term maintenance of both a remission of CD and the healing of fistulas Our main message is that the combination of adalimumab therapy and a standardized management ... evaluated for its efficacy inthe healing of peri-anal fistulas in active CD, there is, as yet, no published data on the use of adalimumab inpatientswith ECF In general, patientswith inflammatory...
... from VA national databases and data analysis, YFL designed the tracking database used inthe process evaluation and assisted with data analysis, AC completed and updated the literature review and ... contains laboratory and other clinical information for all patient encounters The second data source was the VA Pharmacy Benefits Management (PBM) database, which contains detailed medication data ... myocardial infarction), or 414.xx (other forms of ischemic heart disease) inthe VA National Patient Care Databases (NPCD), and if they had been seen in primary care ina VHA hospital at least...
... literature, several different therapeutic approaches have been advanced forthe management of myocardial infarction inpatientswith BD These may include primary percutaneous transluminal coronary ... in 2004 and had been taking warfarin but had discontinued the medication Medical examination revealed blood pressure of 130/70mmHg and heart rate of 85 beats/minute and the patient was pale and ... fibrosis and thus weakens and predisposes the arterial wall to aneurysm formation that eventually ruptures [9] In our patient, angiography was performed for evaluation of coronary anatomy Coronary angiograms...
... from VA national databases and data analysis, YFL designed the tracking database used inthe process evaluation and assisted with data analysis, AC completed and updated the literature review and ... contains laboratory and other clinical information for all patient encounters The second data source was the VA Pharmacy Benefits Management (PBM) database, which contains detailed medication data ... myocardial infarction), or 414.xx (other forms of ischemic heart disease) inthe VA National Patient Care Databases (NPCD), and if they had been seen in primary care ina VHA hospital at least...
... ischemia (Rutherford in 11 patients, Rutherford in 17, and Rutherford in patients) The majority of thepatients (71%) were male and the mean age was 68 (± 11) years Table shows the patient characteristics ... claudication and 3.1 inpatientswith CLI) and the VascuQol domain Activity (4.0 inpatientswith claudication versus 2.4 inpatientswith CLI) The effect size values forthe ALDS and the VascuQol ... of the study and acquisition and analysis of data, and drafting of the manuscript, JAR has been involved inthe design of the study and interpretation of data, as well as in drafting the manuscript,...
... M, Rastan A, Mohr F: Beating heart coronaryartery bypass inpatientswith acute myocardial infarction: a new strategy to protect themyocardium Myocardial Protection Futura Blackwell PublishingSalerno ... perform the necessary distal coronary anastomoses and subsequently the proximal by partial clamping of the aorta (for the cases with more than one graft) After completion of the proximal anastomoses ... significant advantages, especially important in our opinion forthe early and also the late postoperative results: a) it does not aggravate themyocardiumwiththe “toxic influence” of the ischemia...
... dual-lumen catheter with tip position inthe caval vein In agreement withthe functional intra vitam results of our study, catheter position was not the main determinant for Qa inthe way previously assumed ... arteries and the right iliac vein Interestingly, the dual-lumen catheter again was visualized at the lateral wall of the blood vessel Commonly used catheters for renal replacement therapies, plasmapheresis, ... sheath (Arrow Deutschland GmbH) (Alt Cath) for blood delivery in case of insufficient Qb via the arterial line of the duallumen catheter Rinsing of catheters was performed with normal saline and...
... transformation carcinoma, lung adenocarcinoma, in vitro and tumor ovarian cystadenocarcinoma, formation in mice colorectal carcinoma, renal cell (J.K Cheong et al, carcinoma, osteosarcoma and ... peptide-based therapy are envisioned to include cutaneous and intracavitary superficial mucosal lesions such as vulvar intraepithelial neoplasia, cervical dysplasia or carcinoma in situ, oral cancer and ... proteins interact with PHD zinc finger- and /or bromodomain-containing proteins 1.1.4.1 PHD zinc finger domain and proteins The plant homeodomain (PHD) and zinc finger domain is an evolutionarily...